ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TSTL Tristel Plc

480.00
15.00 (3.23%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tristel Plc LSE:TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  15.00 3.23% 480.00 460.00 480.00 470.00 465.00 465.00 33,518 16:35:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 36.01M 4.46M 0.0941 49.95 222.78M
Tristel Plc is listed in the Med, Dental, Hosp Eq-whsl sector of the London Stock Exchange with ticker TSTL. The last closing price for Tristel was 465p. Over the last year, Tristel shares have traded in a share price range of 327.50p to 499.00p.

Tristel currently has 47,400,993 shares in issue. The market capitalisation of Tristel is £222.78 million. Tristel has a price to earnings ratio (PE ratio) of 49.95.

Tristel Share Discussion Threads

Showing 3201 to 3224 of 4000 messages
Chat Pages: Latest  136  135  134  133  132  131  130  129  128  127  126  125  Older
DateSubjectAuthorDiscuss
03/3/2019
06:03
Tristel: Record H1 Results Deliver Wonderful 28% Dividend Lift But Further FDA-Project Mishaps Dash Any Hope Of Early US Sales
28 February 2019
By Maynard Paton

piedro
01/3/2019
07:44
This promising small-cap growth company could crack America!
Kevin Godbold
25 February 2019

piedro
26/2/2019
07:54
Did anyone go the presentations ? If so did they elaborate on this "Furthermore, we have decided that our most prudent approach is to postpone commercialising the EPA approvals already obtained for our Duo and Jet products until we have greater visibility of the way ahead for the FDA project."

It almost suggests that there isn't a market for EPA approved products.

glaws2
26/2/2019
05:31
25 FEBRUARY 2019 INTERIM RESULTS
INVESTOR PRESENTATION
www.tristel.com/sites/default/files/investor_presentation_february_2019.pdf

piedro
25/2/2019
20:39
Bought in at 116p so I'm not complaining. I top-sliced a while ago so I'm staying in for a while a see what happens.
trapperjez
25/2/2019
19:15
You pays your money and takes your chances.

US approval opens a massive market. When and how much that costs is the question ("if" is an altogether different subject).

First time buyer to TSTL? Walk away.

Bought in sub 100p? Stick about and enjoy the ride assuming you have taken a healthy profit and left a few thousand shares for the divi and the "what the hell, let's see where this goes"

zimbtrader
25/2/2019
16:52
"Profits up, share price down..why?"

US approval takes longer and costs more than anticipated. Already an expensive share.

salchow
25/2/2019
16:12
Profits up, share price down..why?
trapperjez
20/2/2019
13:46
Nothing wrong with a bit of scepticism but a bit less cryptic posting would be good then concerns can be understood and discussed.

:-)

melton john
20/2/2019
09:09
Melton John,
As you may have noted, I am distrustful of the BoD
but am invested here for the chemistry and not their charms

They do seem to patrol this site - ssshhhtt !!!

AIMO,

:-)

piedro
19/2/2019
14:39
Piedro gives me the impression that he sold out and regrets it. Can you confirm Piedro?
melton john
19/2/2019
12:12
Thanks for link but you should make others aware that it is almost 5 years old and not NEW as most PIs would assume
djabel666
08/2/2019
18:48
Even ignoring the US and Canada, there are lots of other rollout opportunities for TSTL, in my view. I don't think that the company is remotely x-growth, aside from in the UK NHS market. Even there, there are new products being launched, as noted in various recent posts, but it obviously not the main thrust.
james188
08/2/2019
17:48
Metis and Piedro,
I am not able to grasp the ‘coded’ contents in last two messages. Being a long time holder, curious to know. Could you please explain in simple words.

sportii
08/2/2019
15:05
metis20 -
"If and when" maybe the lifeline people are hoping for
but it could be a hard slog

AIMHO

piedro
08/2/2019
14:26
Piedro - given that the US market is about to open up for TSTL, it would very much surprise me if they are going "x-growth"!
metis20
05/2/2019
08:10
Here he is speaking ...

Bruno Holthof: Lessons from Antwerp Hospital Network


- a rescue job
- and perhaps future chairman ....

piedro
05/2/2019
07:45
thats a great appontment
elcapital2018
05/2/2019
07:27
New Director !!
piedro
05/2/2019
07:19
Sportii,
Tristel publish occasionally on Linkedin and Twitter
It is as though they do not want to be seen
And the information is limited

It would not surprise me if they are going x-growth

AIMHO

piedro
05/2/2019
06:56
What’s on linkndn? Details about new product?
Btw, other posters seem to have left this bb. Not many posts either here or lse. Awaiting Results end of this month. Hope tristel doing well overseas.

sportii
05/2/2019
06:15
- on LinkedIn
piedro
01/2/2019
09:53
No explication on the website ...




- is it not the first place to look?
- looked up 'cache', 'shot' and 'duel' .... but nothing found

- perhaps it is a marketing trick to click up site visits

piedro
01/2/2019
09:45
Tristel Global@TristelGlobal
Introducing Cache, a new range of high-performance
surface disinfectants. #chlorinedioxide #disinfection
#innovation #SHOT #DUEL #JET

piedro
Chat Pages: Latest  136  135  134  133  132  131  130  129  128  127  126  125  Older

Your Recent History

Delayed Upgrade Clock